AgingResearch.NewsJoin free

Peptides

382

Peptides people ask about for aging and recovery, from BPC-157 and epitalon to approved medicines like semaglutide, each with the research on it: how many papers, and how many were in people, in animals and in cells.

Latest stories

International Journal of Cardiology

Obesity drugs linked to fewer cases of a heart rhythm disorder

Over one year, a heart rhythm disorder occurred in 1.63% of drug users and 2.62% of matched nonusers with obesity and chronic kidney disease.Over one year, a heart rhythm disorder occurred in 1.63% of drug users and 2.62% of matched nonusers with obesity and chronic kidney disease.

Cohort studyObesity
Paper
Diabetes, Obesity, and Cardiometabolic CARE

Model projects preventable deaths under limited US obesity care

For 107.6 million US adults with obesity, the simulation estimated 5.3 million preventable deaths over 10 years if treatment was forgone.For 107.6 million US adults with obesity, the simulation estimated 5.3 million preventable deaths over 10 years if treatment was forgone. A computational model simulated 107.6 million US adults with obesity, including people with…

Computational studyObesity
Paper
Science Advances

Layered gel improved spinal disc structure and function in rats

An experiment in rats with severe spinal disc degeneration found that a cell-carrying gel promoted new tissue formation and outperformed cells or a support scaffold…An experiment in rats with severe spinal disc degeneration found that a cell-carrying gel promoted new tissue formation and outperformed cells or a support scaffold alone.

Rat studyInterventions
Paper
Cell Metabolism

A triple-target drug cut body weight by up to 19.7% in a trial

Average body weight fell between 13.6% and 19.7% across drug doses compared with 2.0% on placebo over 24 weeks.Average body weight fell between 13.6% and 19.7% across drug doses compared with 2.0% on placebo over 24 weeks. In a multicenter, double-blind randomized trial, researchers tested the drug UBT251 in 205 adults with overweight or…

Randomized trial in 205 peopleInterventions
Paper

Not approved as medicines

  • MOTS-c

    124 papers: 2 trials and 36 observational studies in people, 58 in animals, 11 in cells, 17 reviews

  • Thymosin alpha 1

    65 papers: 15 trials and 12 observational studies in people, 10 in animals, 8 in cells, 17 reviews

  • Humanin

    114 papers: 1 trial and 24 observational studies in people, 48 in animals, 19 in cells, 19 reviews

  • LL-37

    116 papers: 4 trials and 19 observational studies in people, 22 in animals, 45 in cells, 23 reviews

  • Thymosin beta 4

    50 papers: 2 trials and 4 observational studies in people, 21 in animals, 10 in cells, 13 reviews

  • Petrelintide

    3 papers: 3 trials in people

  • BPC-157

    65 papers: 2 trials in people, 35 in animals, 2 in cells, 26 reviews

  • Carnosine

    23 papers: 1 observational study in people, 9 in animals, 1 in cells, 12 reviews

  • Epitalon

    23 papers: 1 trial in people, 7 in animals, 8 in cells, 7 reviews

  • FOXO4-DRI

    14 papers: 1 observational study in people, 8 in animals, 2 in cells, 2 reviews

  • Gamma-glutamylcysteine

    3 papers: 1 observational study in people, 2 reviews

  • Vgvapg

    3 papers: 1 observational study in people, 2 in animals

  • Humanin P3S

    2 papers: 1 observational study in people, 1 review

  • OS-01

    2 papers: 1 trial in people, 1 review

  • Peptide 14

    2 papers: 1 trial in people, 1 in cells

  • GHK-Cu

    40 papers: none in people yet, 14 in animals, 11 in cells, 8 reviews

  • Semax

    13 papers: none in people yet, 8 in animals, 3 in cells, 2 reviews

  • Angiotensin

    7 papers: none in people yet, 5 in animals, 1 in cells, 1 review

  • Epidermal growth factor

    7 papers: none in people yet, 2 in animals, 5 in cells

  • Delta-sleep-inducing peptide

    6 papers: none in people yet, 5 in animals, 1 in cells

  • Hng

    5 papers: none in people yet, 2 in animals, 2 in cells, 1 review

Approved medicines

Broader groups

303 more peptides, each in 4 papers or fewer